Join our Stock Market News Group at GetPaidIndia on Telegram and WhatsApp.
This website is purely ACADEMIC in nature and NOT a stock market recommendation service or a tip provider. No live data or feeds are provided and all information is historic only. Information is provided for ease of understanding for the purpose of learning. Accuracy of definitions etc is not mantained. I am not a SEBI or IRDA registered.
- May 24, 2017: Audited Standalone and Consolidated Financial Results for the fourth quarter and year ended 31st March, 2017
Net Profit / Loss (Year ending)
|31 March 2016||31 March 2017|
Related Lesson: Learn why investing in profit making companies is better.
Type: Consolidated Basic EPS After Exceptional Item
|EPS||31 March 2016||31 March 2017|
Related Lesson: How much should be ideal Earnings Per Share?
Related / Peer Companies
- Ajanta Pharma Limited
- Alembic Limited
- Cipla Limited (CIPLA)
- Dishman Pharmaceuticals and Chemicals Limited (DISHMAN) (532526) (INE353G01020)
- Dr Reddys Laboratories Limited (DRREDDY) (500124) (INE089A01023)
- Elder Health Care Limited
- Gufic Biosciences Limited (GUFICBIO) (509079) (INE742B01025)
- Hester Biosciences Limited
- Hikal Limited (HIKAL) (524735) (INE475B01022)
- Jubilant Life Sciences Limited (JUBILANT) (530019) (INE700A01033)
- Laurus Labs Limited (LAURUSLABS) (540222) (INE947Q01010)
- Shilpa Medicare Limited (SHILPAMED) (530549) (INE790G01031)
- Vivimed Labs Limited (VIVIMEDLAB) (532660) (INE526G01021)
- Wockhardt Limited (WOCKPHARMA)